MANNHEIM, Germany, and PARIS, France—Serial coronary imaging of patients implanted with a resorbable magnesium scaffold (Dreams 3G; Biotronik) for coronary artery disease suggests “favorable healing” ...
Reva Medical has secured (PDF) the CE marking of its bioresorbable scaffold. The European regulatory nod clears Reva to push a device it thinks addresses some shortcomings of other products in the ...
PARIS, France—In a EuroPCR 2019 session devoted to bioresorbable vascular scaffolds, including the now abandoned Absorb device (Abbott Vascular), investigators dared to raise their hopes on the basis ...
It was back to the drawing board for bioresorbable vascular scaffolds (BVS), to some degree, after the initially promising ABSORB series of trials dampened any enthusiasm for the coronary stent-like ...
SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- The Fantom bioresorbable scaffold from REVA Medical, Inc. (ASX:RVA) shows continued positive clinical outcomes according to an interim data set from the ...
Do you know immunotherapy post-surgery improves overall survival for kidney cancer? Study finds ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A ...
6 August, 2019 – Today, Meril Life Sciences announced that MeRes100 BRS, its indigenously designed and manufactured scaffold, became the first thin-strut bioresorbable scaffold to receive CE marking.
LONDON, July 11, 2019 /PRNewswire/ -- Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis and very low Major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback